Indication

Acinetobacter meningitis

Acinetobacter meningitis is a severe, life-threatening infection of the leptomeninges and cerebrospinal fluid caused by aerobic, Gram-negative bacteria of the genus *Acinetobacter*, predominantly *Acinetobacter baumannii*. Read more about Acinetobacter meningitis

16 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Acinetobacter meningitis therapies.

Showing 10–16 of 16 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Hikma Pharmaceuticals USA

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Avet Pharmaceuticals

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
AVET-NOVAPLUS

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
FRESENIUS KABI

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
MULLAN PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Acinetobacter meningitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acinetobacter meningitis.

Acinetobacter meningitis is a severe, life-threatening infection of the leptomeninges and cerebrospinal fluid caused by aerobic, Gram-negative bacteria of the genus *Acinetobacter*, predominantly *Acinetobacter baumannii*.

It primarily arises as a healthcare-associated or nosocomial infection within intensive care units, disproportionately affecting neurosurgical patients, individuals with traumatic head injuries, and patients with invasive devices such as external ventricular drains, lumbar punctures, or cerebrospinal fluid shunts.

Clinically and pathophysiologically, it is characterized by acute or subacute meningeal inflammation leading to fever, headache, altered mental status, and meningismus, with cerebrospinal fluid analysis typically demonstrating marked neutrophilic pleocytosis, elevated protein levels, and hypoglycorrhachia.

The condition carries substantial morbidity and mortality, frequently compounded by extensive intrinsic and acquired multidrug resistance among circulating strains.

Personalize your experience

Follow Acinetobacter meningitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it